Zobrazeno 1 - 10
of 514
pro vyhledávání: '"K. Koski"'
Publikováno v:
BMC Neuroscience, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background The treatment of Parkinson’s disease is often complicated by levodopa-induced dyskinesia (LID). Nicotinic acetylcholine receptor agonists can alleviate LID in animal models but may be less effective in conditions of severe dopam
Externí odkaz:
https://doaj.org/article/f2833f74947d4bff9346c9681eb8fc45
Publikováno v:
Vaccines, Vol 9, Iss 9, p 1037 (2021)
Preferred methods for generating mouse dendritic cells (DC) would encompass qualities of consistency, high yield, and potent function. Serum-free culture is also highly desirable, since this is the standard for cell-based therapies used in humans. We
Externí odkaz:
https://doaj.org/article/c371ef386b7440b0bd25b565e1ce7eb7
Autor:
Paul J. Zhang, Carl June, Bruce L. Levine, Mark Rosen, Francis R. Spitz, Louis Araujo, Angela DeMichele, George Coukos, Robert Vonderheide, Susan G. Orel, Susan Weinstein, Kevin R. Fox, Min Xu, Terry Pasha, Harvey Nisenbaum, Rosemarie Mick, Peter A. Cohen, Shuwen Xu, Ursula Koldovsky, Gary K. Koski, Brian J. Czerniecki
Supplementary Figure 5 from Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8406e55bb42139cf9fa4e42a069b2e01
https://doi.org/10.1158/0008-5472.22370475.v1
https://doi.org/10.1158/0008-5472.22370475.v1
Autor:
Paul J. Zhang, Carl June, Bruce L. Levine, Mark Rosen, Francis R. Spitz, Louis Araujo, Angela DeMichele, George Coukos, Robert Vonderheide, Susan G. Orel, Susan Weinstein, Kevin R. Fox, Min Xu, Terry Pasha, Harvey Nisenbaum, Rosemarie Mick, Peter A. Cohen, Shuwen Xu, Ursula Koldovsky, Gary K. Koski, Brian J. Czerniecki
Supplementary Figure 4 from Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f33ee09274d325962d62d745e29cce
https://doi.org/10.1158/0008-5472.22370478
https://doi.org/10.1158/0008-5472.22370478
Autor:
Paul J. Zhang, Carl June, Bruce L. Levine, Mark Rosen, Francis R. Spitz, Louis Araujo, Angela DeMichele, George Coukos, Robert Vonderheide, Susan G. Orel, Susan Weinstein, Kevin R. Fox, Min Xu, Terry Pasha, Harvey Nisenbaum, Rosemarie Mick, Peter A. Cohen, Shuwen Xu, Ursula Koldovsky, Gary K. Koski, Brian J. Czerniecki
Supplementary Table 1 from Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c9db9dc364994571eb4c557a639944
https://doi.org/10.1158/0008-5472.22370472
https://doi.org/10.1158/0008-5472.22370472
Autor:
Paul J. Zhang, Carl June, Bruce L. Levine, Mark Rosen, Francis R. Spitz, Louis Araujo, Angela DeMichele, George Coukos, Robert Vonderheide, Susan G. Orel, Susan Weinstein, Kevin R. Fox, Min Xu, Terry Pasha, Harvey Nisenbaum, Rosemarie Mick, Peter A. Cohen, Shuwen Xu, Ursula Koldovsky, Gary K. Koski, Brian J. Czerniecki
Overexpression of HER-2/neu (c-erbB2) is associated with increased risk of recurrent disease in ductal carcinoma in situ (DCIS) and a poorer prognosis in node-positive breast cancer. We therefore examined the early immunotherapeutic targeting of HER-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad1e2a4ccd52a63e8d686932447df4f
https://doi.org/10.1158/0008-5472.c.6496416
https://doi.org/10.1158/0008-5472.c.6496416
Autor:
Paul J. Zhang, Carl June, Bruce L. Levine, Mark Rosen, Francis R. Spitz, Louis Araujo, Angela DeMichele, George Coukos, Robert Vonderheide, Susan G. Orel, Susan Weinstein, Kevin R. Fox, Min Xu, Terry Pasha, Harvey Nisenbaum, Rosemarie Mick, Peter A. Cohen, Shuwen Xu, Ursula Koldovsky, Gary K. Koski, Brian J. Czerniecki
Supplementary Figure 2 from Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a520c933fa1a7499092fc957f257159
https://doi.org/10.1158/0008-5472.22370481.v1
https://doi.org/10.1158/0008-5472.22370481.v1
Publikováno v:
Vaccines, Vol 8, Iss 1, p 72 (2020)
A dendritic cell-based, Type 1 Helper T cell (Th1)-polarizing anti-Human Epidermal Growth Factor Receptor-2 (HER-2) vaccine supplied in the neoadjuvant setting eliminates disease in up to 30% of recipients with HER-2-positive (HER-2pos) ductal carcin
Externí odkaz:
https://doaj.org/article/f19fbcb581f64d0aa7fe3b46b6fcfe57
Autor:
Gary K. Koski, Paulo C. Rodriguez, Ricardo Costa, Corey Gallen, HS Han, Amrita Basu, Peter A. Forsyth, Aixa E. Soyano, Jashodeep Datta, Amber Beyer, Pawel Kalinski, Gabriella Albert, Sabrina Awshah, Brian J. Czerniecki, Hatem Soliman, Marie Catherine Lee, Derek R. Dukett, Keiran S.M. Smalley, Krithika Kodumudi
Publikováno v:
Cancer Immunology Research. 10:108-125
The HER3/ERBB3 receptor is an oncogenic receptor tyrosine kinase that forms heterodimers with EGFR family members and is overexpressed in numerous cancers. HER3 overexpression associates with reduced survival and acquired resistance to targeted thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7064a4b4770c5a2fe89f1363cbf2c92
https://doi.org/10.1158/2326-6066.cir-21-0454
https://doi.org/10.1158/2326-6066.cir-21-0454
Autor:
Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, Megan Fracol, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Robert E. Roses, Carla S. Fisher, Elizabeth S. McDonald, Paul J. Zhang, Angela DeMichele, Rosemarie Mick, Gary K. Koski, Brian J. Czerniecki
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
HER2-directed therapies are less effective in patients with ERpos compared to ERneg breast cancer, possibly reflecting bidirectional activation between HER2 and estrogen signaling pathways. We investigated dual blockade using anti-HER2 vaccination an
Externí odkaz:
https://doaj.org/article/40a1bfb17d064e669d6b75faf357fb2e